| Financial Year |
March 31 2023 |
| Monetary Funds |
41,167,042.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
3,127,067.66 |
| Other Receivables |
68,456,902.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,788,115.16 |
| Inventories |
1,940,787,489.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
73,144,302.36 |
| Total Current Assets |
2,126,682,804.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
86,937,787.96 |
| Investment Properties |
-- |
| Fixed Assetes |
3,201,187.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
2,981,526.60 |
| Long-Term Deferred and Prepaid Expenses |
842,866.70 |
| Deferred Income Tax Assets |
32,288,966.14 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
166,475,209.44 |
| Total Assets |
2,293,158,014.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
414,047,504.55 |
| Accounts Received In Advance |
60,098.49 |
| Employee Compensation Payable |
9,481,479.63 |
| Taxes Payable |
25,138,298.17 |
| Interest Payable |
16,792,373.03 |
| Dividend Payable |
1,262,968.30 |
| Other payables |
151,551,218.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
222,747,326.90 |
| Other Current Liabilities |
63,002,543.17 |
| Sub-Total of Current Liabilities |
1,259,373,826.18 |
| Long-term Loans |
481,528,453.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,722,642.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
487,202,716.29 |
| Total Liabilities |
1,746,576,542.47 |
| Paid-In Capital(Or Share Stock) |
299,265,522.00 |
| Capital Surplus |
41,485,419.75 |
| Surplus Reserve |
139,985,058.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
65,996,543.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
546,581,471.64 |
| Owner's Equity（Stockholder's Equity） |
546,581,471.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,293,158,014.11 |
